NCCN Updates 2014 Guidelines

291 views

Published on

The National Comprehensive Cancer Network updated its NCNN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy as a treatment option for prostate cancer. Illinois CyberKnife specializes in stereotactic radiosurgery and stereotactic body radiation therapy using CyberKnife® technology. If you are interested in learning more about Illinois CyberKnife, call 847-723-0100 to speak with a representative.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
291
On SlideShare
0
From Embeds
0
Number of Embeds
8
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

NCCN Updates 2014 Guidelines

  1. 1. CyberKnife offers prostate cancer patients a noninvasive treatment option that re- quires no anesthesia. Patients experience few to no side effects and return to their normal routines after treatment. “ ” Opened in 2011 in partnership with Advocate Lutheran General Hospital, Illinois CyberKnife specializes in stereotactic radiosurgery and stereotactic body radiation therapy using CyberKnife® technology. About Illinois CyberKnife IllinoisCK.com - 847-723-0100 - 1700 Luther Lane, Suite 1110, Park Ridge, Illinois 60068 National Comprehensive Cancer Network (NCCN) Guidelines for Prostate Cancer • In January 2014, the NCCN updated its NCCN Clinical Practice Guidelines in Oncology® to include stereotactic body radiation therapy (SBRT) as a treatment option for prostate cancer. To review the complete guidelines visit www.NCCN.org. • NCCN is an alliance of 23 of the world’s leading cancer centers. These institutions work together to develop treatment guidelines for many cancers and are dedicated to research that improves the quality of cancer care. • The update to the NCCN Guidelines demonstrates acceptance and support of SBRT as a treatment option for prostate cancer from a leading, world-renown coalition of cancer centers. • NCCN Guidelines are developed and updated annually by nearly 950 clinical professionals and researchers from the NCCN member institutions. • The guidelines assist individuals involved in cancercare,suchasphysicians,nurses,patientsand their families, with the decision-making process and are intended to advance the fight against cancer. • The NCCN update follows a 2013 published model coverage policy by the American Society for Radiation Oncology(ASTRO).The policy developed by ASTRO helps insurance companies provide insurance benefits to men for the treatment of prostate cancer. To review the complete model policy visit www.astro.org. The information contained in this document is presented in summary form only and is not intended to replace or serve as a substitute for your duty to verify that such information is proper for your patient’s signs, symptoms, conditions or circumstance(s). - Dr. Arica Hirsch, Illinois CyberKnife Medical Director

×